Omnia Molecular
Latest round
- Series B
Last raised
- Jun 2011
Total raised
- $3.9M
Investors
- 3
About Omnia Molecular
Omnia Molecular is devoted to the discovery and development of new anti-infective compounds.
Who invested in Omnia Molecular
3 investors across 2 rounds
See all investors in Omnia Molecular
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Omnia Molecular
Who invested in Omnia Molecular?
Omnia Molecular has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Omnia Molecular raised?
Omnia Molecular has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Omnia Molecular last raise money?
Omnia Molecular's most recent round on record is a Series B, in Jun 2011.
What does Omnia Molecular do?
Omnia Molecular is devoted to the discovery and development of new anti-infective compounds.
Where is Omnia Molecular headquartered?
Omnia Molecular is headquartered in Barcelona, Spain.
Which VCs invest in companies like Omnia Molecular?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Omnia Molecular's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Omnia Molecular? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.